References:

1. Supporting references for therapeutic utility of epigenetic reprogramming:

   Disease Model	Intervention	Reference
   Type I diabetes	Partial OSKM, transgenic	https://pubmed.ncbi.nlm.nih.gov/27984723/
   Skeletal muscle injury	Partial OSKM, transgenic	https://pubmed.ncbi.nlm.nih.gov/27984723/
   Skeletal muscle injury	OSKMLN, mRNA + LNPs	https://pubmed.ncbi.nlm.nih.gov/32210226/
   Skeletal muscle injury	OSKM, transgenic	https://pubmed.ncbi.nlm.nih.gov/34035273/
   Glaucoma	Partial OSK, AAV	https://pubmed.ncbi.nlm.nih.gov/33268865/
   Myocardial infarction	Partial OSKM, transgenic	https://pubmed.ncbi.nlm.nih.gov/34554778/
   Skin wound healing	Partial OSKM, transgenic	https://pubmed.ncbi.nlm.nih.gov/29761584/
   Skin wound healing	Partial OSKM, long-term, transgenic	https://www.nature.com/articles/s43587-022-00183-2#Sec28
   Liver regeneration	Partial OSKM, transgenic	https://pubmed.ncbi.nlm.nih.gov/35476977/